APA (7th ed.) Citation

Vinod Anera Balakrishna, Anitha Police, Rakesh Hiremath, Anusha Raj, Suresh P Sulochana, Devaraj V Chandrasekhar, . . . Ramesh Mullangi. (2017). Preclinical assessment of ulixertinib, a novel ERK1/2 inhibitor. International Association of Physical Chemists (IAPC).

Chicago Style (17th ed.) Citation

Vinod Anera Balakrishna, Anitha Police, Rakesh Hiremath, Anusha Raj, Suresh P Sulochana, Devaraj V Chandrasekhar, Zainuddin Mohd, Ravi Kanth Bhamidipati, and Ramesh Mullangi. Preclinical Assessment of Ulixertinib, a Novel ERK1/2 Inhibitor. International Association of Physical Chemists (IAPC), 2017.

MLA (9th ed.) Citation

Vinod Anera Balakrishna, et al. Preclinical Assessment of Ulixertinib, a Novel ERK1/2 Inhibitor. International Association of Physical Chemists (IAPC), 2017.